Dominance and Market Definition in the Pharmaceutical Industry Following the ECJ Paroxetine Judgment

被引:1
|
作者
Neven, Damien [1 ,2 ]
Siotis, Georges [2 ,3 ]
机构
[1] Grad Inst Int & Dev Studies, Geneva, Switzerland
[2] CEPR, London, England
[3] Univ Carlos III Madrid, Madrid, Spain
关键词
D O I
10.1093/jeclap/lpaa016
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
[No abstract available]
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [1] Product market definition in the pharmaceutical industry
    Morse, MH
    [J]. ANTITRUST LAW JOURNAL, 2003, 71 (02) : 633 - 676
  • [2] DEFINITION OF INDUSTRY AND MARKET
    NIGHTINGALE, J
    [J]. JOURNAL OF INDUSTRIAL ECONOMICS, 1978, 27 (01): : 31 - 40
  • [3] Market definition in the telecoms industry
    Gual, J
    [J]. ECONOMICS OF ANTITRUST AND REGULATION IN TELECOMMUNICATIONS: PERSPECTIVES FOR THE NEW EUROPEAN REGULATORY FRAMEWORK, 2004, : 45 - 70
  • [4] The return of the pharmaceutical industry to the market
    Johansson, EDB
    [J]. STEROIDS, 2000, 65 (10-11) : 709 - 711
  • [5] Romanian Market Strategies in the Pharmaceutical Industry
    Opris, Mircea Constantin
    Deselnicu, Dana Corina
    Crasoveanu, Fowzi-Constantin
    [J]. PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BUSINESS EXCELLENCE, 2023, 17 (01): : 1404 - 1412
  • [6] Relevant Market Definition and Market Dominance Identification in 3Q War
    Huang Wei
    Han Guizhen
    [J]. COMPETITION POLICY INTERNATIONAL, 2015, 11 (01): : 62 - 70
  • [7] Is there a Role for Market Definition and Dominance in an effects-based Approach?
    Arezzo, Emanuela
    [J]. ABUSE OF DOMINANT POSITION: NEW INTERPRETATION, NEW ENFORCEMENT MECHANISMS?, 2008, : 21 - 54
  • [8] TECHNICAL PROGRESS AND MARKET POWER IN THE PHARMACEUTICAL INDUSTRY
    Gallego, Jose
    [J]. DYNA-COLOMBIA, 2009, 76 (159): : 93 - 102
  • [9] BIOTECH INDUSTRY MOVING PHARMACEUTICAL PRODUCTS TO MARKET
    BAUM, RM
    [J]. CHEMICAL & ENGINEERING NEWS, 1987, 65 (29) : 11 - &
  • [10] MARKET MORTALITY OF NEW PRODUCTS IN PHARMACEUTICAL INDUSTRY
    NORWOOD, GJ
    SMITH, MC
    [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1971, NS11 (11): : 592 - &